DXR Share Price

Open 8.53 Change Price %
High 8.59 1 Day 0.04 0.47
Low 8.53 1 Week 0.18 2.14
Close 8.59 1 Month 0.11 1.30
Volume 1203 1 Year 0.91 11.85
52 Week High 9.80
52 Week Low 0.00
DXR Important Levels
Resistance 2 8.65
Resistance 1 8.62
Pivot 8.57
Support 1 8.56
Support 2 8.53
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
RBY 0.03 -70.00%
NAK 2.46 -2.77%
NAK 2.46 -2.77%
NGD 4.16 1.22%
NGD 4.16 1.22%
PBTH 8.23 0.37%
BTI 116.76 2.29%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
GMO 0.38 22.58%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
INV 0.14 -17.65%
More..

Daxor Corporation (AMEX: DXR)

DXR Technical Analysis 3
As on 19th Jan 2017 DXR Share Price closed @ 8.59 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.14 & Buy for SHORT-TERM with Stoploss of 8.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
DXR Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
DXR Other Details
Segment EQ
Market Capital 33775400.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.daxor.com
DXR Address
DXR
Empire State Building
350 Fifth Avenue
New York, NY 10118
United States
Phone: 212-244-0555
Fax: 212-244-0806
DXR Latest News
Chart Indicators in Focus for Daxor Corp. (DXR)   Yankee Analysts   - 20th Jan 17
Daxor Co. (DXR) Chairman Acquires $1462000.00 in Stock   Sports Perspectives   - 12th Jan 17
Joseph Feldschuh Purchases 172000 Shares of Daxor Co. (DXR) Stock   Community Financial News   - 11th Jan 17
Daxor Co. (DXR) Chairman Joseph Feldschuh Acquires 172000 Shares   The Cerbat Gem   - 10th Jan 17
Form 4 DAXOR CORP For: Jan 04 Filed by: Feldschuh Michael Richard   StreetInsider.com   - 09th Jan 17
Daxor Corporation (DXR) Ex-Dividend Date Scheduled for December 20, 2016   Nasdaq   - 19th Dec 16
Daxor Corporation Announces Dividend, Patent Approval, Title Change   Marketwired (press release)   - 19th Nov 16
Daxor Corp. (DXR) Names New CFO   StreetInsider.com   - 17th Jun 16
Sperm bank accused of discarding hazardous materials   New York Post   - 17th Jul 15
Daxor Corporation Announces Filing of Form N-CSR for December 31, 2014   Marketwired (press release)   - 27th Feb 15
Interactive Technical Analysis Chart Daxor Corporation ( DXR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Daxor Corporation
DXR Business Profile
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.